Document is current
Any future updates will be listed below
-
Authors
Arevalo, John https://orcid.org/0000-0002-1138-5036
Su, Ellen https://orcid.org/0009-0007-8934-8642
Ewald, Jessica D. https://orcid.org/0000-0002-7555-736X
van Dijk, Robert
Carpenter, Anne E. https://orcid.org/0000-0003-1555-8261
Singh, Shantanu https://orcid.org/0000-0003-3150-3025
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM122547, R35 GM122547, R35 GM122547, R35 GM122547, R35 GM122547, R35 GM122547)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Massachusetts Life Sciences Center
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 29 August 2023
Accepted: 13 July 2024
First Online: 2 August 2024
Competing interests
: The Authors declare the following competing interests: S.S. and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C: Recursion, SyzOnc, Quiver Bioscience, S.S.: Waypoint Bio, Dewpoint Therapeutics, Deepcell) and receive honoraria for occasional scientific visits to pharmaceutical and biotechnology companies. All other authors declare no competing interests.
